01 1Hamari PFST, Ltd.
02 1Kolon Life Science Co., Ltd.
01 1HKINNOEN Co., Ltd.
02 1Kolon Life Science Co., Ltd.
01 1Boglibos
02 1Voglibose
01 1Japan
02 1South Korea
Registrant Name : HKINNOEN Co., Ltd.
Registration Date : 2021-05-17
Registration Number : 20210517-209-J-756
Manufacturer Name : Hamari PFST, Ltd.
Manufacturer Address : 2-4300-18, Hachimampara, Yonezawa, Yamagata, Japan
Registrant Name : Kolon Life Science Co., Ltd.
Registration Date : 2024-10-28
Registration Number : 20241028-209-J-1708
Manufacturer Name : Kolon Life Science Co., Ltd.
Manufacturer Address : 54, Gippdosi-ro 1, Daesowon-myeon, Chungju-si, Chungcheongbuk-do
27
PharmaCompass offers a list of Voglibose API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Voglibose manufacturer or Voglibose supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Voglibose manufacturer or Voglibose supplier.
PharmaCompass also assists you with knowing the Voglibose API Price utilized in the formulation of products. Voglibose API Price is not always fixed or binding as the Voglibose Price is obtained through a variety of data sources. The Voglibose Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 3,4-Dideoxy-4-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-D-epi-inositol; N-(1,3-Dihydroxyprop-2-yl)valiolamine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 3,4-Dideoxy-4-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-D-epi-inositol; N-(1,3-Dihydroxyprop-2-yl)valiolamine, including repackagers and relabelers. The FDA regulates 3,4-Dideoxy-4-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-D-epi-inositol; N-(1,3-Dihydroxyprop-2-yl)valiolamine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 3,4-Dideoxy-4-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-D-epi-inositol; N-(1,3-Dihydroxyprop-2-yl)valiolamine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 3,4-Dideoxy-4-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-D-epi-inositol; N-(1,3-Dihydroxyprop-2-yl)valiolamine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 3,4-Dideoxy-4-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-D-epi-inositol; N-(1,3-Dihydroxyprop-2-yl)valiolamine supplier is an individual or a company that provides 3,4-Dideoxy-4-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-D-epi-inositol; N-(1,3-Dihydroxyprop-2-yl)valiolamine active pharmaceutical ingredient (API) or 3,4-Dideoxy-4-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-D-epi-inositol; N-(1,3-Dihydroxyprop-2-yl)valiolamine finished formulations upon request. The 3,4-Dideoxy-4-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-D-epi-inositol; N-(1,3-Dihydroxyprop-2-yl)valiolamine suppliers may include 3,4-Dideoxy-4-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-D-epi-inositol; N-(1,3-Dihydroxyprop-2-yl)valiolamine API manufacturers, exporters, distributors and traders.
click here to find a list of 3,4-Dideoxy-4-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-D-epi-inositol; N-(1,3-Dihydroxyprop-2-yl)valiolamine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a 3,4-Dideoxy-4-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-D-epi-inositol; N-(1,3-Dihydroxyprop-2-yl)valiolamine Drug Master File in Korea (3,4-Dideoxy-4-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-D-epi-inositol; N-(1,3-Dihydroxyprop-2-yl)valiolamine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of 3,4-Dideoxy-4-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-D-epi-inositol; N-(1,3-Dihydroxyprop-2-yl)valiolamine. The MFDS reviews the 3,4-Dideoxy-4-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-D-epi-inositol; N-(1,3-Dihydroxyprop-2-yl)valiolamine KDMF as part of the drug registration process and uses the information provided in the 3,4-Dideoxy-4-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-D-epi-inositol; N-(1,3-Dihydroxyprop-2-yl)valiolamine KDMF to evaluate the safety and efficacy of the drug.
After submitting a 3,4-Dideoxy-4-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-D-epi-inositol; N-(1,3-Dihydroxyprop-2-yl)valiolamine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their 3,4-Dideoxy-4-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-D-epi-inositol; N-(1,3-Dihydroxyprop-2-yl)valiolamine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of 3,4-Dideoxy-4-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-D-epi-inositol; N-(1,3-Dihydroxyprop-2-yl)valiolamine suppliers with KDMF on PharmaCompass.
We have 2 companies offering 3,4-Dideoxy-4-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-D-epi-inositol; N-(1,3-Dihydroxyprop-2-yl)valiolamine
Get in contact with the supplier of your choice:
